Yalonda Howze Codiak Bio Sciences, Inc. (CDAK) insider trading activity

Yalonda Howze is of Codiak BioSciences, Inc.. Currently has a direct ownership of 7,458 shares of CDAK, which is worth approximately $74. The most recent transaction as insider was on Mar 30, 2023, when has been sold 1,628 shares (Common Stock) at a price of $0.2 per share, resulting in proceeds of $325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.46K

0% 3M change

0% 12M change

Total Value Held $74

Yalonda Howze Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 30 2023	SELL Open market or private sale	$325 $0.2 p/Share	1,628 Reduced 17.92%	7,458 Common Stock
Feb 17 2023	SELL Open market or private sale	$945 $0.59 p/Share	1,603 Reduced 15.0%	9,086 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	4,856 Added 31.24%	10,689 Common Stock
Jan 20 2023	SELL Open market or private sale	$876 $0.58 p/Share	1,512 Reduced 37.8%	2,488 Common Stock
Jan 19 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 50.0%	4,000 Common Stock
Aug 17 2022	SELL Open market or private sale	$3,341 $2.21 p/Share	1,512 Reduced 20.59%	5,833 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	4,857 Added 39.8%	7,345 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

CHIEF LEGAL OFFICER

Yalonda Howze

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDAK shares.

Notify only if

Value

Insider Trading

Get notified when an Codiak Bio Sciences, Inc. insider buys or sells CDAK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Codiak BioSciences, Inc.

Track Activities on CDAK

Account